Kazia Therapeutics Limited (KZIA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Kazia Therapeutics Limite...

    NASDAQ: KZIA · Real-Time Price · USD
    8.02
    -0.08 (-0.99%)
    At close: Sep 09, 2025, 11:13 AM

    Kazia Therapeutics Income Statement

    Financials in AUD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
    Revenue
    		 2.31M 555.00 25.00 15.18M
    Cost of Revenue
    		 n/a n/a n/a n/a
    Gross Profit
    		 2.31M 555.00 25.00 15.18M
    Operating Income
    		 n/a -24.12M -26.7M -6.38M
    Interest Income
    		 12K 22.56K 2.09K 42.24K
    Pretax Income
    		 -27.05M -20.74M -25.02M -8.91M
    Net Income
    		 -26.78M -20.47M -24.65M -8.42M
    Selling & General & Admin
    		 13.56M 8.58M 4.64M 7.02M
    Research & Development
    		 17.38M 15.56M 20.25M 14.54M
    Other Expenses
    		 -28.64M -22.56K -10K n/a
    Operating Expenses
    		 2.31M 24.12M 24.88M 24.13M
    Interest Expense
    		 n/a n/a 2.09K n/a
    Selling & Marketing Expenses
    		 n/a n/a 127.04K n/a
    Cost & Expenses
    		 2.31M 24.12M 24.88M 24.13M
    Income Tax Expense
    		 -271K 271.09K -368.08K 484.35K
    Shares Outstanding (Basic)
    		 479.6K 368.6K 265K 235.4K
    Shares Outstanding (Diluted)
    		 479.6K 368.6K 265K 235.4K
    EPS (Basic)
    		 -55.85 -55.55 -93.05 -35.8
    EPS (Diluted)
    		 -55.85 -55.55 -93.05 -35.8
    EBITDA
    		 -26.77M -22.28M -23.51M -5.11M
    EBIT
    		 -28.64M -24.15M -25.38M -6.38M
    Depreciation & Amortization
    		 1.87M 1.87M 1.87M 1.26M

    Add to Watchlist